Bill

Bill > HB1339


TX HB1339

TX HB1339
Relating to designating certain substances as Schedule IV controlled substances under the Texas Controlled Substances Act.


summary

Introduced
11/14/2024
In Committee
03/10/2025
Crossed Over
Passed
Dead
06/02/2025

Introduced Session

89th Legislature Regular Session

Bill Summary

AN ACT relating to designating certain substances as Schedule IV controlled substances under the Texas Controlled Substances Act.

AI Summary

This bill amends the Texas Health and Safety Code to expand the list of substances classified as Schedule IV controlled substances. Currently, carisoprodol is the only substance in this category, but the bill adds two additional medications: mifepristone and misoprostol. Mifepristone is a medication primarily used for medical abortion, while misoprostol is a drug used to prevent stomach ulcers and also used in combination with mifepristone for medical abortion procedures. The bill specifies that the new classification will only apply to offenses committed on or after its effective date, which is September 1, 2025. By adding these substances to Schedule IV, the bill subjects them to additional regulatory controls and potential legal consequences related to their unauthorized possession, distribution, or use. The change does not criminalize the medical use of these medications when prescribed by a licensed healthcare professional, but rather establishes a legal framework for monitoring and controlling their distribution.

Committee Categories

Health and Social Services

Sponsors (2)

Last Action

Referred to Public Health (on 03/10/2025)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...